Hormonal contraception and breast cancer risk;Hormonelle kontrazeption und brustkrebsrisiko

Wiener Medizinische Wochenschrift

Volumn 160, Issue 19-20, 2010, Pages 483-486

  Bjelic Radisic, Vesna ^a   Petru, Edgar ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

BRCA1 and 2; Breast cancer; Gestagens; Levonorgestrel intrauterine device; Oral contraceptives

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CONTRACEPTIVE AGENT; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

AGE; ARTICLE; BREAST CANCER; CANCER RISK; FAMILIAL CANCER; GENE MUTATION; HORMONAL CONTRACEPTION; HUMAN; META ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK; YOUNG ADULT;

EID: 78651386210     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0807-0     Document Type: Article

References (20)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer (CGHFBC). Breast cancer and hormonal contraceptives: collaborative reanalyses of individual data on 53297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347:1713-1727, 1996.
2. Lilienfeld AM. The relationship of cancer of the female breast to artificial menopause and martial status. Cancer, 9:927-934, 1956.
3. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med, 312:146-151, 1985.
4. Bland KL. Risk factors as an indicator for breast cancer screening in asymptomatic patients. Maturitas, 9:135-161, 1987.
5. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses Health Study. Am J Epidemiol, 139:315-329, 1994.
6. Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol, 129:269-280, 1989. (Pubitemid 19046994)
7. UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet, i: 973-982, 1989.
8. Meirik O, Lund E, Adami H-O, et al. Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway. Lancet, ii: 650-654, 1986.
9. Royal College of General Practitioners. Breast cancer and oral contraceptives: Findings in Royal College of General Proacticioners' Study. Br Med J, 282:2089-2093, 1981.
10. Kay CR, Hannaford PC. Breast cancer and the pill-a further report from the Royal College of General Practicioners Oral Contraception Study. Br J Cancer, 58:675-680, 1988.
11. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med, 346:2025-2032, 2002.
12. Kumle M, Weiderpass E, Braaten T, et al. Use of oral contraceptives and breast cancer risk, the Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol, 11:1375-1381, 2002.
13. Milne RL, Knight JA, John EM, et al. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol, 14:350-356, 2005.
14. Vessey MP, Villard-Mackintosh L, McPherson K, et al. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. BMJ 299:1487-1491, 1989.
15. Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practicioners' Oral Contraception Study. BMJ, 318:96-100, 1999.
16. Shapiro S, Rosenberg L, Hoffman M, et al. Risk of brest cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol, 151:396-403, 2000.
17. Skegg DC, Noonan EA, Paul C, et al. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA, 273:799-804, 1995.
18. Backman T, Rauramo I, Jaakkola K, et al. Use of the levonorgestrelreleasing intrauterine system and breast cancer. Obstet Gynecol, 106:813-817, 2005.
19. Grabick D, Hartmann L, Cerhan J, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA, 284:1791-1798, 2000.
20. Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception, 80:372-380, 2009.